[Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I].
Andreoli L, Nalli C, Motta M, Norman GL, Binder WL, Nuzzo M, Frassi M, Lojacono A, Avcin T, Meroni PL, et al. Reumatismo. 2010 Jul-Sep; 62(3):189-94.